View of Comparative Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction, and Cardiometabolic Risk in Patients with Type 2 Diabetes

Return to Article Details Comparative Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction, and Cardiometabolic Risk in Patients with Type 2 Diabetes Download Download PDF